Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > NLSP NLS Pharmaceutics > Detailed Quotes

NLSP NLS Pharmaceutics

Watchlist
0.840
+0.010+1.20%
Close 12/01 16:00 ET
High
0.850
Open
0.815
Turnover
35.08K
Low
0.780
Pre Close
0.830
Volume
42.78K
Market Cap
23.16M
P/E(TTM)
Loss
52wk High
2.400
Shares
27.57M
P/E(Static)
Loss
52wk Low
0.330
Float Cap
18.47M
Bid/Ask %
-71.43%
Historical High
7.350
Shs Float
21.99M
Volume Ratio
0.09
Historical Low
0.330
Dividend TTM
--
Div Yield TTM
--
P/B
-5.71
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.20%
Amplitude
8.41%
Avg Price
0.820
Lot Size
1
Float Cap
18.47M
Bid/Ask %
-71.43%
Historical High
7.350
Shs Float
21.99M
Volume Ratio
0.09
Historical Low
0.330
Dividend TTM
--
P/B
-5.71
Dividend LFY
--
Turnover Ratio
0.20%
Amplitude
8.41%
Avg Price
0.820
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
NLS Pharmaceutics AG engages in the discovery and development of drug therapies to treat rare and complex central nervous systems disorders. These disorders include narcolepsy, idiopathic hypersomnia and other rare sleep disorders, and of neurodevelopmental disorders, such as ADHD. The company was founded by Ronald Hafner and Alexander Zwyer in August 2015 and is headquartered in Stans, Switzerland.
CEO: Mr. Alexander Zwyer
Market: NASDAQ
Listing Date: 01/29/2021
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist